Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04254003 · ClinicalTrials.gov registry record · NA
Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT04254003: Completed NA study, sponsored by Alcon Research.
NCT04254003 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04254003, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the rotational behavior of DT1 Toric contact lenses.
Primary Outcome
A slit lamp will be used to observe axis orientation.
Interventions
- DEVICE DT1 Toric contact lenses
- DEVICE AO1DfA contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-02-05 |
| Est. Completion | 2020-03-02 |
| Phase | NA |
What the finished NCT04254003 record still lists
NCT04254003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which DT1 Toric contact lenses is the first listed.
NCT04254003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04254003 about?
NCT04254003 is a clinical study titled "Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses". The purpose of this study is to evaluate the rotational behavior of DT1 Toric contact lenses.
What is the current status of trial NCT04254003?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2020-02-05. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT04254003?
The interventions under investigation include: DT1 Toric contact lenses (DEVICE), AO1DfA contact lenses (DEVICE).
Who is sponsoring clinical trial NCT04254003?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04254003's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI